Compare PEG & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PEG | CNC |
|---|---|---|
| Founded | 1903 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.6B | 33.5B |
| IPO Year | 1994 | 2001 |
| Metric | PEG | CNC |
|---|---|---|
| Price | $74.52 | $66.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 16 |
| Target Price | ★ $92.79 | $46.75 |
| AVG Volume (30 Days) | 2.9M | ★ 4.2M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.37% | N/A |
| EPS Growth | ★ 19.21 | N/A |
| EPS | 2.15 | ★ 5.30 |
| Revenue | $12,168,000,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $4.89 | $8.31 |
| Revenue Next Year | $4.16 | $1.05 |
| P/E Ratio | $35.19 | ★ $12.41 |
| Revenue Growth | 18.25 | ★ 19.44 |
| 52 Week Low | $74.20 | $25.42 |
| 52 Week High | $88.65 | $69.36 |
| Indicator | PEG | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 31.04 | 55.73 |
| Support Level | N/A | $63.20 |
| Resistance Level | $81.50 | $68.40 |
| Average True Range (ATR) | 1.55 | 2.93 |
| MACD | -0.37 | 0.14 |
| Stochastic Oscillator | 4.73 | 85.40 |
Public Service Enterprise Group is the holding company for a regulated utility (PSE&G) and PSEG Power, which owns all or a share of three nuclear plants and clean energy projects. PSE&G provides regulated gas and electricity delivery services in New Jersey to a combined 4.3 million customers. Public Service Enterprise Group also operates the Long Island Power Authority system under a contract extension through 2030. In 2022, the company sold its gas and oil power plants in the mid-Atlantic, New York, and the Northeast.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.